Breast Cancer Screening by Landmine Detection Technology
Breast cancer is the most common cause of death in women between the ages of 35 and 55 in Europe.
A British research company is planning to develop microwave radar as a means of screening for breast cancer.
Breast cancer screening presently uses X-rays which pose their own hazards, especially for younger women who have to undergo tests.
Bristol University spin out company, Micrima, has received a £150,000 investment from NESTA (National Endowment for Science, Technology and the Arts).
Micrima’s microwave radar technology has the potential to revolutionise breast screening as it can offer a quick method of imaging which may help avoid unnecessary and expensive biopsies.
This technology was originally developed for detecting buried landmines.
Mark White, NESTA Invention and Innovation Director, said “Through investing in its innovative technology early on we are looking to ensure that this idea has every opportunity of being fully commercialised, benefiting so many thousands of women, those working in healthcare, and the UK economy.”
